{"id":"https://openalex.org/W4385850536","doi":"https://doi.org/10.1080/03007995.2023.2247969","title":"Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT","display_name":"Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT","publication_year":2023,"publication_date":"2023-08-16","ids":{"openalex":"https://openalex.org/W4385850536","doi":"https://doi.org/10.1080/03007995.2023.2247969","pmid":"https://pubmed.ncbi.nlm.nih.gov/37583267"},"language":"en","primary_location":{"id":"doi:10.1080/03007995.2023.2247969","doi":"https://doi.org/10.1080/03007995.2023.2247969","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2023.2247969","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/03007995.2023.2247969","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005195192","display_name":"Daiana Stolz","orcid":"https://orcid.org/0000-0003-0099-882X","observed_orcids":["https://orcid.org/0000-0003-0099-882X"]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]},{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Daiana Stolz","raw_affiliation_strings":["Clinic of Respiratory Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of Respiratory Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068702887","display_name":"Erik Hermansson","orcid":"https://orcid.org/0000-0002-9850-9563","observed_orcids":["https://orcid.org/0000-0002-9850-9563"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Erik Hermansson","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055776171","display_name":"Mario Ouwens","orcid":"https://orcid.org/0000-0002-9004-8918","observed_orcids":["https://orcid.org/0000-0002-9004-8918","https://orcid.org/0000-0002-8357-8080"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mario Ouwens","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111477763","display_name":"Barinder Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284127","display_name":"Pharmacoevidence (India)","ror":"https://ror.org/02zaj1j33","country_code":"IN","type":"company","lineage":["https://openalex.org/I4405284127"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Barinder Singh","raw_affiliation_strings":["Pharmacoevidence, Mohali, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoevidence, Mohali, India","institution_ids":["https://openalex.org/I4405284127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054110856","display_name":"Akanksha Sharma","orcid":"https://orcid.org/0009-0002-7840-3240","observed_orcids":["https://orcid.org/0009-0002-7840-3240"]},"institutions":[{"id":"https://openalex.org/I4405284127","display_name":"Pharmacoevidence (India)","ror":"https://ror.org/02zaj1j33","country_code":"IN","type":"company","lineage":["https://openalex.org/I4405284127"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Akanksha Sharma","raw_affiliation_strings":["Pharmacoevidence, Mohali, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoevidence, Mohali, India","institution_ids":["https://openalex.org/I4405284127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043222919","display_name":"Dan Jackson","orcid":"https://orcid.org/0000-0002-4963-8123","observed_orcids":["https://orcid.org/0000-0002-4963-8123"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dan Jackson","raw_affiliation_strings":["AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027975503","display_name":"Patrick F. Darken","orcid":"https://orcid.org/0000-0002-5608-2717","observed_orcids":["https://orcid.org/0000-0002-5608-2717"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Darken","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002192542","display_name":"Jonathan Marshall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Marshall","raw_affiliation_strings":["AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110767855","display_name":"Karin Bowen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Bowen","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023632504","display_name":"Hana M\u00fcllerov\u00e1","orcid":"https://orcid.org/0000-0002-0949-0101","observed_orcids":["https://orcid.org/0000-0002-0949-0101"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hana M\u00fcllerov\u00e1","raw_affiliation_strings":["AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038171945","display_name":"Bernardino Alc\u00e1zar Navarrete","orcid":"https://orcid.org/0000-0003-2356-9366","observed_orcids":["https://orcid.org/0000-0003-2356-9366"]},"institutions":[{"id":"https://openalex.org/I4210113665","display_name":"Instituto de Investigaci\u00f3n Biosanitaria de Granada","ror":"https://ror.org/026yy9j15","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113665"]},{"id":"https://openalex.org/I4210116170","display_name":"Hospital Universitario Virgen de las Nieves","ror":"https://ror.org/02f01mz90","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210116170"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bernardino Alc\u00e1zar Navarrete","raw_affiliation_strings":["Instituto Biosanitario de Granada, IBS-Granada, Granada, Spain","Respiratory Department, Hospital Universitario Virgen de las Nieves, Granada, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Biosanitario de Granada, IBS-Granada, Granada, Spain","institution_ids":["https://openalex.org/I4210113665"]},{"raw_affiliation_string":"Respiratory Department, Hospital Universitario Virgen de las Nieves, Granada, Spain","institution_ids":["https://openalex.org/I4210116170"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Russell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Russell","raw_affiliation_strings":["King\u2019s Centre for Lung Health, Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King\u2019s Centre for Lung Health, Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026096786","display_name":"MeiLan King Han","orcid":"https://orcid.org/0000-0002-9095-4419","observed_orcids":["https://orcid.org/0000-0002-9095-4419"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MeiLan K. Han","raw_affiliation_strings":["Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085233858","display_name":"Deniz Tansey-Dwyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deniz Tansey-Dwyer","raw_affiliation_strings":["AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5005195192"],"corresponding_institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"],"apc_list":null,"apc_paid":null,"fwci":2.5422,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.90155427,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"39","issue":"10","first_page":"1395","last_page":"1405"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.859000027179718},{"id":"https://openalex.org/keywords/budesonide-glycopyrrolate-formoterol-fumarate","display_name":"budesonide/glycopyrrolate/formoterol fumarate","score":0.9279999732971191},{"id":"https://openalex.org/keywords/fluticasone-furoate-umeclidinium-vilanterol","display_name":"fluticasone furoate/umeclidinium/vilanterol","score":0.9890000224113464},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.878000020980835},{"id":"https://openalex.org/keywords/matching-adjusted-indirect-comparison","display_name":"matching-adjusted indirect comparison","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ethos-trial","display_name":"ETHOS trial","score":0.906000018119812},{"id":"https://openalex.org/keywords/impact-trial","display_name":"IMPACT trial","score":1.0},{"id":"https://openalex.org/keywords/mortality-risk-reduction","display_name":"mortality risk reduction","score":0.6830000281333923},{"id":"https://openalex.org/keywords/head-to-head-comparison","display_name":"head-to-head comparison","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9339423775672913},{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.8221820592880249},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.6637662053108215},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.6525759696960449},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.5586390495300293},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.47876110672950745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45222336053848267},{"id":"https://openalex.org/C2780911369","wikidata":"https://www.wikidata.org/wiki/Q753853","display_name":"Lama","level":3,"score":0.43330317735671997},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3831841051578522},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.3392670750617981}],"mesh":[{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/03007995.2023.2247969","doi":"https://doi.org/10.1080/03007995.2023.2247969","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2023.2247969","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:37583267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37583267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Comparative Study"},{"id":"pmh:oai:kclpure.kcl.ac.uk:openaire/6a5ba4a1-ace8-4711-9861-c5661ef35114","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/6a5ba4a1-ace8-4711-9861-c5661ef35114","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1080/03007995.2023.2247969","doi":"https://doi.org/10.1080/03007995.2023.2247969","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2023.2247969","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7275711376","display_name":null,"funder_award_id":"GPP 2022","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1931149717","https://openalex.org/W1964129893","https://openalex.org/W1980003405","https://openalex.org/W1982967337","https://openalex.org/W2002726093","https://openalex.org/W2029770479","https://openalex.org/W2054931962","https://openalex.org/W2077523026","https://openalex.org/W2084883728","https://openalex.org/W2092901728","https://openalex.org/W2111722183","https://openalex.org/W2131237771","https://openalex.org/W2513086234","https://openalex.org/W2604577460","https://openalex.org/W2650689221","https://openalex.org/W2753051611","https://openalex.org/W2758779514","https://openalex.org/W2761239349","https://openalex.org/W2765538469","https://openalex.org/W2785999277","https://openalex.org/W2789802763","https://openalex.org/W2802221596","https://openalex.org/W2803032401","https://openalex.org/W2890279735","https://openalex.org/W2891482814","https://openalex.org/W2899736836","https://openalex.org/W2904964912","https://openalex.org/W2905313402","https://openalex.org/W2955635155","https://openalex.org/W2969213710","https://openalex.org/W3011621519","https://openalex.org/W3037411127","https://openalex.org/W3108245859","https://openalex.org/W3110411875","https://openalex.org/W3123416722","https://openalex.org/W3134436843","https://openalex.org/W3160347722","https://openalex.org/W3175777329","https://openalex.org/W4206353597","https://openalex.org/W4214942997","https://openalex.org/W4225166709","https://openalex.org/W4288074822","https://openalex.org/W4288925984","https://openalex.org/W4289338622","https://openalex.org/W4293733558","https://openalex.org/W4297474261","https://openalex.org/W4367601141"],"related_works":["https://openalex.org/W4367600056","https://openalex.org/W4293148442","https://openalex.org/W3011621519","https://openalex.org/W4318827356","https://openalex.org/W3108245859","https://openalex.org/W4396515649","https://openalex.org/W4205437324","https://openalex.org/W2891482814","https://openalex.org/W4225166709","https://openalex.org/W7169800656"],"abstract_inverted_index":{"Objective":[0],"Chronic":[1],"obstructive":[2],"pulmonary":[3],"disease":[4],"(COPD)":[5],"is":[6],"a":[7,72,107,163],"leading":[8],"cause":[9],"of":[10,45,88,118,146],"death":[11],"worldwide.":[12],"While":[13],"two":[14,82],"approved":[15],"fixed-dose":[16],"inhaled":[17],"corticosteroid/long-acting":[18],"muscarinic":[19],"antagonist":[20],"(LAMA)/long-acting":[21],"\u03b22-agonist":[22],"(LABA)":[23],"triple":[24,100],"therapies":[25,47],"reduce":[26],"all-cause":[27],"mortality":[28],"(ACM)":[29],"versus":[30,65,196,242],"dual":[31],"LAMA/LABA":[32],"therapy":[33],"in":[34,53,63,69,97,130,198,244],"patients":[35,98,131,245],"with":[36,55,132,240,246],"COPD,":[37],"head-to-head":[38],"studies":[39,83],"have":[40],"not":[41,178],"compared":[42,51,113],"the":[43,142,147,199],"effects":[44],"these":[46,174],"on":[48],"ACM.":[49],"We":[50],"ACM":[52,92,114,184,236],"adults":[54],"moderate-to-very":[56,133,247],"severe":[57,134,248],"COPD":[58],"receiving":[59,99],"budesonide/glycopyrrolate/formoterol":[60],"fumarate":[61],"(BGF)":[62],"ETHOS":[64,103,123,233],"fluticasone":[66],"furoate/umeclidinium/vilanterol":[67],"(FF/UMEC/VI)":[68],"IMPACT":[70,86,105,129],"using":[71,159],"matching-adjusted":[73],"indirect":[74,166],"comparison":[75,168],"(MAIC).Methods":[76],"A":[77],"systematic":[78],"literature":[79],"review":[80],"identified":[81],"(ETHOS":[84],"[NCT02465567];":[85],"[NCT02164513])":[87],"\u226552":[89],"weeks":[90,187],"reporting":[91],"as":[93],"an":[94,110],"efficacy":[95],"endpoint":[96],"therapy.":[101],"As":[102],"and":[104,124,138,212,234],"lack":[106],"common":[108],"comparator,":[109],"unanchored":[111],"MAIC":[112,200],"between":[115,232],"licensed":[116],"doses":[117],"BGF":[119,150,195,241],"(320/18/9.6":[120],"\u03bcg)":[121,127],"from":[122,128,141],"FF/UMEC/VI":[125,157,197,243],"(100/62.5/25":[126],"COPD.":[135,249],"Using":[136],"on-":[137],"off-treatment":[139],"data":[140,151,158],"final":[143],"retrieved":[144],"datasets":[145],"intention-to-treat":[148],"populations,":[149],"were":[152],"adjusted":[153,179,228],"according":[154],"to":[155],"aggregate":[156],"11":[160],"baseline":[161],"covariates;":[162],"supplementary":[164],"unadjusted":[165,213],"treatment":[167],"was":[169,188,237],"also":[170],"conducted.":[171],"P-values":[172],"for":[173,180,194,229],"post-hoc":[175],"analyses":[176],"are":[177],"Type":[181],"I":[182],"error.Results":[183],"over":[185],"52":[186],"statistically":[189],"significantly":[190,238],"reduced":[191,239],"by":[192],"39%":[193],"(hazard":[201],"ratio":[202],"[HR]":[203],"[95%":[204,216],"CI]:":[205,217],"0.61":[206,218],"[0.38,":[207],"0.95],":[208],"P":[209,221],"=":[210,222],"0.030)":[211],"analysis":[214],"(HR":[215],"[0.41,":[219],"0.92],":[220],"0.019).Conclusion":[223],"In":[224],"this":[225],"MAIC,":[226],"which":[227],"population":[230],"heterogeneity":[231],"IMPACT,":[235]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-17T00:00:00"}